{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:58:12Z","timestamp":1793750292853,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD034320"],"award-info":[{"award-number":["1S10OD034320"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-049917"],"award-info":[{"award-number":["INV-049917"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007493","name":"University of Colorado Boulder","doi-asserted-by":"publisher","award":["SCR_019309"],"award-info":[{"award-number":["SCR_019309"]}],"id":[{"id":"10.13039\/100007493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007493","name":"University of Colorado Boulder","doi-asserted-by":"publisher","award":["SCR_018302"],"award-info":[{"award-number":["SCR_018302"]}],"id":[{"id":"10.13039\/100007493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","award":["N332-GT2"],"award-info":[{"award-number":["N332-GT2"]}],"id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xphs.2025.104066","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T09:59:46Z","timestamp":1763373586000},"page":"104066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lipid-free, thermostable mRNA vaccines prepared using atomic layer deposition"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2412-6946","authenticated-orcid":false,"given":"Holly J.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-1911","authenticated-orcid":false,"given":"Erika","family":"Langsfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0926-1640","authenticated-orcid":false,"given":"Urvi","family":"Parlikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5109-6389","authenticated-orcid":false,"given":"Robert L.","family":"Garcea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4292-4047","authenticated-orcid":false,"given":"Theodore W.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0001","first-page":"1","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.xphs.2025.104066_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100424","article-title":"Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs","volume":"41","author":"Suzuki","year":"2021","journal-title":"Drug Metab Pharmacokinet"},{"issue":"19","key":"10.1016\/j.xphs.2025.104066_bib0003","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1016\/j.cell.2024.07.021","article-title":"Transforming vaccinology","volume":"187","author":"Rappuoli","year":"2024","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.xphs.2025.104066_bib0004","first-page":"1","article-title":"A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike","volume":"110","author":"Zhang","year":"2022","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.xphs.2025.104066_bib0005","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1007\/s12274-018-2091-z","article-title":"Recent advances in mRNA vaccine delivery","volume":"11","author":"Tan","year":"2018","journal-title":"Nano Res"},{"issue":"7","key":"10.1016\/j.xphs.2025.104066_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics15071972","article-title":"Recent advancement in mRNA vaccine development and applications","volume":"15","author":"Al Fayez","year":"2023","journal-title":"Pharmaceutics"},{"issue":"37","key":"10.1016\/j.xphs.2025.104066_bib0007","first-page":"1","article-title":"A comparison of plasmid DNA and mRNA as vaccine technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.xphs.2025.104066_bib0008","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.xphs.2025.104066_bib0009","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles","volume":"8","author":"Su","year":"2011","journal-title":"Mol Pharm"},{"issue":"709","key":"10.1016\/j.xphs.2025.104066_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci Transl Med"},{"issue":"26","key":"10.1016\/j.xphs.2025.104066_bib0011","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301606120","article-title":"Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination","volume":"120","author":"Ben-Akiva","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.xphs.2025.104066_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2014.06.048","article-title":"Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery","volume":"189","author":"Mccarthy","year":"2014","journal-title":"J Control Rel"},{"issue":"6","key":"10.1016\/j.xphs.2025.104066_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13060877","article-title":"Protamine-based strategies for RNA transfection","volume":"13","author":"Jarzebska","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0014","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/10717544.2020.1790692","article-title":"Functional differences between protamine preparations for the transfection of mRNA","volume":"27","author":"Jarzebska","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2025.104066_bib0015","first-page":"11","article-title":"Delivery strategies for mRNA vaccines","volume":"36","author":"Ramachandran","year":"2022","journal-title":"Pharmaceut Med"},{"issue":"11","key":"10.1016\/j.xphs.2025.104066_bib0016","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"March","key":"10.1016\/j.xphs.2025.104066_bib0017","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2025.104066_bib0018","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0019","first-page":"1","article-title":"Payload distribution and capacity of mRNA lipid nanoparticles","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.xphs.2025.104066_bib0020","series-title":"Liposomal Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetic and Bioavailability; and Labeling Documentation","year":"2018"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-26926-0","article-title":"A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems","volume":"12","author":"Packer","year":"2021","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.xphs.2025.104066_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab764","article-title":"Theoretical basis for stabilizing messenger RNA through secondary structure design","volume":"49","author":"Wayment-Steele","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xphs.2025.104066_bib0023","series-title":"SPIKEVAX Label","first-page":"0","year":"2024"},{"key":"10.1016\/j.xphs.2025.104066_bib0024","series-title":"COMIRNATY Label","first-page":"0","year":"2024"},{"key":"10.1016\/j.xphs.2025.104066_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126648","article-title":"Left out in the cold - inequity in infectious disease control due to cold chain disparity","volume":"45","author":"Talbot","year":"2025","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.xphs.2025.104066_bib0026","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/17425247.2022.2135502","article-title":"Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications","volume":"19","author":"Lopes","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"issue":"33","key":"10.1016\/j.xphs.2025.104066_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2303567120","article-title":"Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticles","volume":"120","author":"Shepherd","year":"2023","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.xphs.2025.104066_bib0028","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cvde.200506392","article-title":"Nanocoating individual silica nanoparticles by atomic layer deposition in a fluidized bed reactor","volume":"11","author":"Hakim","year":"2005","journal-title":"Chem Vap Depos"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-018-4442-9","article-title":"Particle atomic layer deposition","volume":"21","author":"Weimer","year":"2019","journal-title":"J Nanoparticle Res"},{"key":"10.1016\/j.xphs.2025.104066_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.powtec.2011.12.020","article-title":"Functionalization of fine particles using atomic and molecular layer deposition","volume":"221","author":"King","year":"2012","journal-title":"Powder Technol"},{"issue":"45","key":"10.1016\/j.xphs.2025.104066_bib0031","first-page":"1","article-title":"Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology","volume":"5","author":"Garcea","year":"2020","journal-title":"Nat Partn J Vacc"},{"issue":"5","key":"10.1016\/j.xphs.2025.104066_bib0032","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.xphs.2022.01.013","article-title":"Atomic-layer deposition processes applied to phage \u03bb and a phage-like particle platform yield thermostable, single-shot vaccines","volume":"111","author":"Witeof","year":"2022","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2025.104066_bib0033","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.xphs.2024.08.005","article-title":"Formulation of three tailed bacteriophages by spray-drying and atomic layer deposition for thermal stability and controlled release","volume":"113","author":"Coleman","year":"2024","journal-title":"J Pharm Sci"},{"issue":"23","key":"10.1016\/j.xphs.2025.104066_bib0034","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.vaccine.2018.04.055","article-title":"Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56\/CAF01 formulated as a spray-dried powder","volume":"36","author":"Thakur","year":"2018","journal-title":"Vaccine"},{"issue":"September 2020","key":"10.1016\/j.xphs.2025.104066_bib0035","article-title":"Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate","volume":"593","author":"Gomez","year":"2021","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2025.104066_bib0036","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.0611430104","article-title":"Drying a tuberculosis vaccine without freezing","volume":"104","author":"Wong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.xphs.2025.104066_bib0037","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.xphs.2024.04.012","article-title":"Stabilization of an infectious enveloped virus by spray-drying and lyophilization","volume":"113","author":"Coleman","year":"2024","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymeth.2006.05.017","article-title":"Microparticle-based technologies for vaccines","volume":"40","author":"O\u2019Hagan","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-45281-4","article-title":"Nominally identical microplastic models differ greatly in their particle-cell interactions","volume":"15","author":"Wieland","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.xphs.2025.104066_bib0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0142-9612(88)90033-6","article-title":"Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage","volume":"9","author":"Tabata","year":"1988","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.xphs.2025.104066_bib0041","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JVI.03473-14","article-title":"A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene","volume":"89","author":"Pugach","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.xphs.2025.104066_bib0042","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41467-017-01549-6","article-title":"Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding","volume":"8","author":"Kulp","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.xphs.2025.104066_bib0043","series-title":"Lipid NanoParticles Results Physico-Chemical Characterization of LNPs","article-title":"NanOZ-LNP TM","author":"Biosciences","year":"2022"},{"issue":"9","key":"10.1016\/j.xphs.2025.104066_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103936","article-title":"Superior immune responses from thermostable, single-administration rabies vaccines prepared using atomic layer deposition","volume":"114","author":"Randolph","year":"2025","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104066_bib0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2017.06.046","article-title":"Production and characterization of aluminium oxide nanoshells on spray dried lactose","volume":"529","author":"Hellrup","year":"2017","journal-title":"Int J Pharm"},{"issue":"761","key":"10.1016\/j.xphs.2025.104066_bib0046","first-page":"1","article-title":"Demonstration of tunable control over a delayed-release vaccine using atomic layer deposition","volume":"12","author":"Brubaker","year":"2024","journal-title":"Vaccines"},{"issue":"7929","key":"10.1016\/j.xphs.2025.104066_bib0047","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41586-022-05216-9","article-title":"Long-primed germinal centres with enduring affinity maturation and clonal migration","volume":"609","author":"Lee","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.xphs.2025.104066_bib0048","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1023\/A:1012192725996","article-title":"Thermophysical properties of trehalose and its concentrated aqueous solutions","volume":"14","author":"Miller","year":"1997","journal-title":"Pharm Res"},{"issue":"6697","key":"10.1016\/j.xphs.2025.104066_bib0049","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.adj8321","article-title":"Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates","volume":"384","author":"Steichen","year":"2024","journal-title":"Science"},{"issue":"May","key":"10.1016\/j.xphs.2025.104066_bib0050","article-title":"Measuring of IgG2c isotype instead of IgG2a in immunized C57BL\/6 mice with Plasmodium vivax TRAP as a subunit vaccine candidate in order to correct interpretation of Th1 versus Th2 immune response","volume":"216","author":"Nazeri","year":"2020","journal-title":"Exp Parasitol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0051","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vaccine.2015.10.132","article-title":"A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens","volume":"34","author":"Swaminathan","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.xphs.2025.104066_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041289","article-title":"Multicomponent lipid nanoparticles for RNA transfection","volume":"15","author":"Gretskaya","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2025.104066_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng Transl Med"},{"issue":"December 2021","key":"10.1016\/j.xphs.2025.104066_bib0054","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jconrel.2021.12.008","article-title":"The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency","volume":"342","author":"Anderluzzi","year":"2022","journal-title":"J Control Release"},{"issue":"13","key":"10.1016\/j.xphs.2025.104066_bib0055","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"February","key":"10.1016\/j.xphs.2025.104066_bib0056","first-page":"1","article-title":"Modulation of immune responses by particle size and shape","volume":"11","author":"Baranov","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104066_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102083","article-title":"mRNA vaccine trafficking and resulting protein expression after intramuscular administration","volume":"35","author":"Hassett","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"10.1016\/j.xphs.2025.104066_bib0058","first-page":"1","article-title":"SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"757","key":"10.1016\/j.xphs.2025.104066_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.adm8451","article-title":"Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70","volume":"16","author":"Brook","year":"2024","journal-title":"Sci Transl Med"},{"issue":"7830","key":"10.1016\/j.xphs.2025.104066_bib0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2025.104066_bib0061","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","article-title":"Th1 memory: implications for vaccine development","volume":"211","author":"Foulds","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.xphs.2025.104066_bib0062","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2021.01.016","article-title":"Stability of lyophilized and spray dried vaccine formulations","volume":"171","author":"Preston","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"May","key":"10.1016\/j.xphs.2025.104066_bib0063","article-title":"Stabilization of HSV-2 viral vaccine candidate by spray drying","volume":"569","author":"LeClair","year":"2019","journal-title":"Int J Pharm"},{"issue":"August","key":"10.1016\/j.xphs.2025.104066_bib0064","article-title":"Spray-dried anti-Campylobacter bacteriophage CP30A powder suitable for global distribution without cold chain infrastructure","volume":"569","author":"Carrigy","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.104066_bib0065","series-title":"Handbook of Pharmaceutical Excipients","year":"2009"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:21:33Z","timestamp":1773832893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022354925005209"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104066","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-free, thermostable mRNA vaccines prepared using atomic layer deposition","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104066"}}